Literature DB >> 16837634

Anemia as a predictor of cardiovascular events in patients with elevated serum creatinine.

Alexander M Walker1, Gary Schneider, Jason Yeaw, Beth Nordstrom, Sean Robbins, Daniel Pettitt.   

Abstract

Patients with anemia and patients with chronic kidney disease have elevated risks for cardiovascular disease. Available studies have been too small to provide details about the relationship or to provide for extensive covariate control. In a large insurance database with linked laboratory values, records of women with serum creatinine >1.2 mg/dl and men with serum creatinine >1.4 mg/dl, identified from July 2000 through June 2003, were sought, and the insurance claims searches for hospitalizations that were associated with myocardial infarction, coronary revascularization, unstable angina, stroke, or congestive heart failure. New onset of dialysis also was sought. Multivariate Poisson regression was used to estimate rate ratios for these events at various hemoglobin (Hb) levels, with adjustment for patient characteristics and previous event history. Among 88,657 patients with high serum creatinine, the risk for hospitalization with myocardial infarction was two to five times higher in anemic (Hb <12 g/dl) patients than in people with Hb from 12.0 to 12.9 g/dl. A similar but less dramatic pattern of higher incidence of coronary revascularization was observed with lower Hb levels. Risks for hospitalization with congestive heart failure declined regularly with increasing Hb levels from a doubling of risk at Hb <10 g/dl to a 61% decrease at 15 g/dl, both relative to 12.0 to 12.9 g/dl. The risk for progression to dialysis was only slightly elevated (7 to 34%) in anemic patients. Anemia raises the risk for cardiovascular disease in patients with elevated serum creatinine.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16837634     DOI: 10.1681/ASN.2005020183

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  30 in total

Review 1.  Cardiovascular risk factors following renal transplant.

Authors:  Jill Neale; Alice C Smith
Journal:  World J Transplant       Date:  2015-12-24

2.  Are we approaching a new era in the treatment of anemia of chronic kidney disease patients?

Authors:  Francesco Locatelli; Lucia Del Vecchio
Journal:  Ann Transl Med       Date:  2019-12

3.  Responsiveness to erythropoiesis-stimulating agents and renal survival in patients with chronic kidney disease.

Authors:  Michio Kuwahara; Shintaro Mandai; Yuri Kasagi; Keita Kusaka; Tomomi Tanaka; Satomi Shikuma; Wataru Akita
Journal:  Clin Exp Nephrol       Date:  2014-09-03       Impact factor: 2.801

4.  Effects of three kinds of erythropoiesis-stimulating agents on renal anemia in Japanese non-dialysis chronic kidney disease patients.

Authors:  Michio Kuwahara; Syoko Hasumi; Shintaro Mandai; Tomomi Tanaka; Satomi Shikuma; Wataru Akita; Yoshihiro Mori; Sei Sasaki
Journal:  Clin Exp Nephrol       Date:  2013-12-07       Impact factor: 2.801

5.  Darbepoetin Alfa in Patients with Advanced CKD without Diabetes: Randomized, Controlled Trial.

Authors:  Terumasa Hayashi; Shoichi Maruyama; Masaomi Nangaku; Ichiei Narita; Hideki Hirakata; Kenichiro Tanabe; Satoshi Morita; Yoshiharu Tsubakihara; Enyu Imai; Tadao Akizawa
Journal:  Clin J Am Soc Nephrol       Date:  2020-04-03       Impact factor: 8.237

6.  Tracking early readmission after pancreatectomy to index and nonindex institutions: a more accurate assessment of readmission.

Authors:  Jeffrey J Tosoian; Caitlin W Hicks; John L Cameron; Vicente Valero; Frederic E Eckhauser; Kenzo Hirose; Martin A Makary; Timothy M Pawlik; Nita Ahuja; Matthew J Weiss; Christopher L Wolfgang
Journal:  JAMA Surg       Date:  2015-02       Impact factor: 14.766

Review 7.  The role of anemia management in improving outcomes for African-Americans with chronic kidney disease.

Authors:  Janice P Lea; Keith Norris; Lawrence Agodoa
Journal:  Am J Nephrol       Date:  2008-04-24       Impact factor: 3.754

8.  Endothelial activation markers in anemic non-dialysis chronic kidney disease patients.

Authors:  Tejas V Patel; Bharati V Mittal; Sai Ram Keithi-Reddy; Jeremy S Duffield; Ajay K Singh
Journal:  Nephron Clin Pract       Date:  2008-10-31

9.  Impact of renal dysfunction on clinical outcomes of acute coronary syndrome.

Authors:  Yong Un Kang; Myung Ho Jeong; Soo Wan Kim
Journal:  Yonsei Med J       Date:  2009-08-19       Impact factor: 2.759

10.  The impact of renal insufficiency and anaemia on survival in patients with cardiovascular disease: a cohort study.

Authors:  Jocelyn Anderson; Liam G Glynn; John Newell; Alberto A Iglesias; Donal Reddan; Andrew W Murphy
Journal:  BMC Cardiovasc Disord       Date:  2009-11-12       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.